U.S. healthcare gets plenty of bang for its buck out of community health workers (CHWs), according to a systematic review of the relevant published research.
No group fared particularly well in an analysis from Trilliant Health looking at publicly reported data. Most of the new utilization of mental health services was for anxiety, with women seeking care most often.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
When preparing for life as both doctors and parents, new mothers and mothers-to-be suffer significantly less burnout if they’re supported by targeted, well-planned support.
Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.
The Centers for Medicare & Medicaid Services said it’s issuing a nationwide moratorium on new providers entering the spaces until it has a chance to look into allegations of fraud, waste and abuse. It confirmed investigations of various organizations are pending.
For the first time, research has identified diaphragmatic dome height measured on chest X-rays as an indicator of what patients’ post-op recovery will look like following surgery for cancer or other lung disorders.
Stroke is still a leading cause of death all over the world. A new AI model showed early potential to anticipate such adverse outcomes up to a decade in advance, ensuring high-risk patients receive the care they need.
U.S. healthcare gets plenty of bang for its buck out of community health workers (CHWs), according to a systematic review of the relevant published research.
No group fared particularly well in an analysis from Trilliant Health looking at publicly reported data. Most of the new utilization of mental health services was for anxiety, with women seeking care most often.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
